// App-Quantinova.ai

: EXPERIENCE OF TREATMENT WITH EDOXABAN IN 552 PATIENTS. SUBANALYSIS BASED ON CREATININE CLEARANCE.

Researchers

Presenter

  • Almudena Garcia Ruiz

Principal Investigators

  • Pablo Romero Garcia

  • Marta Rivas Luque

  • Estefana Morente Constantin

  • Gemma Salas Camacho

  • Pilar Garrido Collado

  • Manuel Jurado Chacn

Medical Centers

  • n Clinica Hematologia y Hemoterapia, Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Unidad de Cuidados Intensivos,Complejo Asistencial de Soria,Soria,Spain

  • Servicio de Hematología y Hemoterapia,Hospital Santa Ana,Motril,Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Non-valvular atrial fibrillation

  • Deep vein thrombosis

  • Arrhythmia

  • Venous thrombosis

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved